Clinical Trial Update: Cilengitide in Treating Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Cilengitide was studied in a Phase 2 trial for prostate cancer, including recurrent disease and various stages, with the study completed and results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Stage Iia Prostate Cancer
• Stage Iib Prostate Cancer

Drugs mentioned

• cilengitide (cilengitide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Prostate Cancer, Stage I Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-04-28